Finance

Lists
Why is 532834 up 6,63%?
Dive Deeper
532834:BOM
Camlin Fine Sciences Ltd
96,00 ₹
+6,63%
(+5,97) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532834...
Open
89,52 ₹
High
98,00 ₹
Low
89,43 ₹
Mkt. cap
18,33 մլրդ
Avg. vol.
45,48 հզր
Volume
204,63 հզր
P/E ratio
338,86
52-wk high
204,35 ₹
52-wk low
88,27 ₹
EPS
0,28 ₹
Shares outstanding
121,25 մլն
No. of employees
674
Open
89,52 ₹
High
98,00 ₹
Low
89,43 ₹
Mkt. cap
18,33 մլրդ
Avg. vol.
45,48 հզր
Volume
204,63 հզր
P/E ratio
338,86
52-wk high
204,35 ₹
52-wk low
88,27 ₹
EPS
0,28 ₹
Shares outstanding
121,25 մլն
No. of employees
674
News stories
From web sources and news partners
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees674
Founded1931
Headquarters-
SectorSpeciality chemicals
Last report
11 օգս, 2026 թ.
Fiscal period
Q1 2027
-0,99 ₹ / 0,12 ₹
-921,17%miss
Revenue / Est. (INR)
5,20 մլրդ / 5,11 մլրդ
+1,66%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
4,60 մլրդ
4,57 մլրդ
3,83 մլրդ
5,20 մլրդ
Cost of goods sold
2,47 մլրդ
2,48 մլրդ
2,24 մլրդ
3,06 մլրդ
Cost of revenue
2,47 մլրդ
2,48 մլրդ
2,24 մլրդ
3,06 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
602,93 մլն
637,64 մլն
886,99 մլն
734,29 մլն
Operating expense
1,99 մլրդ
2,04 մլրդ
1,52 մլրդ
2,16 մլրդ
Total operating expenses
4,45 մլրդ
4,52 մլրդ
3,76 մլրդ
5,21 մլրդ
Operating income
145,85 մլն
53,04 մլն
65,46 մլն
-15,12 մլն
Other non operating income
17,20 մլն
29,36 մլն
-94,79 մլն
13,40 մլն
EBT including unusual items
-923,00 հզր
-278,54 մլն
2,25 մլն
-322,59 մլն
EBT excluding unusual items
-923,00 հզր
-103,43 մլն
94,48 մլն
-211,49 մլն
Income tax expense
59,12 մլն
452,00 հզր
-64,02 մլն
-4,63 մլն
Effective tax rate
-6 405,31%
-0,16%
-2 849,31%
1,44%
Other operating expenses
1,19 մլրդ
1,23 մլրդ
449,93 մլն
1,23 մլրդ
Net income
-143,84 մլն
-362,30 մլն
882,02 մլն
-317,06 մլն
Net profit margin
-3,13%
-7,92%
23,05%
-6,10%
Earnings per share
-0,29
-0,94
0,76
-0,99
Interest and investment income
-
-
79,64 մլն
-
Interest expense
-152,05 մլն
-183,29 մլն
-76,78 մլն
-162,78 մլն
Net interest expenses
-152,05 մլն
-183,29 մլն
2,86 մլն
-162,78 մլն
Depreciation and amortization charges
188,27 մլն
167,28 մլն
184,44 մլն
191,56 մլն
EBITDA
324,59 մլն
203,20 մլն
199,10 մլն
118,52 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps